Management of cardiac arrhythmia.
Cardiac arrhythmia management has advanced substantially and many patients are now being offered curative treatment. There is still much to do and therefore substantial research opportunities. Technical advances with better imaging and mapping datasets, improved ablation catheters and new devices to protect against SCD are all on the horizon. The genetic contribution to arrhythmias is now firmly established and preclinical functional studies will lead to more detailed phenotyping of patients leading to more rational targeting of drugs, catheter ablation and devices.
Grace
Andrew
A
Papworth Hospital, Cambridge. ag@bioc.cam.ac.uk
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000175:diagnosis / Q000628:therapy*; D017115:Catheter Ablation / Q000379:methods; D016757:Death, Sudden, Cardiac / Q000517:prevention & control; D017147:Defibrillators, Implantable; D006801:Humans; D018570:Risk Assessment
D000889:Anti-Arrhythmia Agents